Ligand validation:5L9O

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L9O_EDO_A_306	54%	79%	0.149	0.914	0.52	0.28	-	-	3	0	100%	1
5L9O_EDO_B_304	47%	74%	0.171	0.913	0.44	0.45	-	-	3	0	100%	1
5L9O_EDO_A_304	41%	74%	0.136	0.849	0.51	0.39	-	-	0	0	100%	1
5L9O_EDO_B_302	23%	73%	0.241	0.872	0.41	0.51	-	-	1	0	100%	1
5L9O_EDO_B_303	22%	76%	0.126	0.744	0.54	0.32	-	-	0	0	100%	1
5L9O_EDO_A_305	22%	75%	0.139	0.755	0.54	0.34	-	-	0	0	100%	1
5L9O_EDO_A_302	15%	77%	0.153	0.72	0.52	0.31	-	-	0	0	100%	1
5L9O_EDO_B_305	14%	77%	0.13	0.687	0.52	0.31	-	-	1	0	100%	1
5L9O_EDO_A_307	11%	78%	0.159	0.685	0.56	0.27	-	-	0	0	100%	1
5L9O_EDO_A_303	3%	74%	0.153	0.512	0.5	0.39	-	-	0	0	100%	1
6HQH_EDO_A_303	52%	83%	0.117	0.874	0.54	0.2	-	-	0	0	100%	1
5LOM_EDO_B_302	19%	76%	0.173	0.771	0.53	0.33	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	79%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1
5BV2_EDO_P_811	100%	81%	0.013	0.998	0.34	0.41	-	-	0	0	100%	1
5MZ2_EDO_B_903	100%	83%	0.012	0.998	0.49	0.24	-	-	0	0	100%	1
3QNB_EDO_B_1	100%	64%	0.016	0.998	0.45	0.76	-	-	2	0	100%	1
3UXJ_EDO_B_291	100%	65%	0.017	0.998	0.66	0.55	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.